← All Sponsors
SPONSOR

Shandong Tumor Hospital

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Gastric CancerSecond-line Therapy

Shandong Tumor Hospital is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Gastric Cancer, Second-line Therapy.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Shandong Tumor Hospital

How many clinical trials has Shandong Tumor Hospital sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Shandong Tumor Hospital, of which 1 are actively recruiting participants. These trials cover conditions including Gastric Cancer, Second-line Therapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shandong Tumor Hospital research focus on?
Shandong Tumor Hospital clinical trials span Gastric Cancer, Second-line Therapy. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shandong Tumor Hospital clinical trial?
To participate in a Shandong Tumor Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shandong Tumor Hospital trials with current recruitment status updated daily.

Clinical Trials by Shandong Tumor Hospital

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology